Valeant and Actavis end merger talks

If this email is not displayed correctly, please click on the following link or open your browser and paste the link into the address field: http://view.ed4.net/v/FG6LAA/A5ULWE/P54FKO/KE63S1/   Breaking news Saturday April 27 2013 Breaking News   Valeant and Actavis end merger talks Valeant Pharmaceuticals International and generic drugmaker Actavis have called off talks that would have brought together two companies with a combined market capitalisation of $35bn. http://link.ft.com/r/FG6LAA/3CKP9P/UU56TC/YBUBTT/RPM4LP/MQ/h?a1=2013&a2=4&a3=27 Tools Your account    Portfolio Email Briefings    Price alerts Keyword alerts    RSS feeds Subscribe to FT.com     © THE FINANCIAL TIMES LTD 2013 ABOUT THIS EMAIL You have received this email because you have signed up from the NBE preference page. FT.com Change Briefings  •   Unsubscribe  •   Change Email Address  •   Forward this email to a friend  •   Privacy Policy  •   About Us  •   Help This email was sent by or on behalf of a company owned by Pearson plc, registered office at 80 Strand, London WC2R 0RL. Registered in England and Wales with company number 53723..